Aditya Puri, former HDFC Bank MD has joined global pharmaceutical giant Strides Group as an advisor and as a director of its associate company Stelis Biopharma.
In a regulatory filing on Friday, Strides Pharma Science Ltd said, “Eminent corporate doyen Aditya Puri joins the Strides Group as an advisor and also will be a director of its associate company, Stelis Biopharma.”
Strides Pharma Science said Puri’s appointment to the Stelis board comes at an exciting juncture for the company as it transitions from its incubation phase to a consolidation and growth phase to establish itself as a partner of choice globally with the aim of bringing world-class treatments at affordable costs to patients in both emerging and developed markets.
Aditya Puri said the Stride Group’s established parentage, global success and headstart in terms of basic infrastructure gives him the opportunity to be involved in and guide Stelis and other Group endeavours in their exciting growth story.
Arun Kumar, Founder and Chairman of the Board of Strides, said “I am delighted to welcome Aditya as our advisor and to the Stelis board. This a huge vote of confidence in the potential of Stelis. Aditya’s illustrious legacy is well-known. Having nurtured HDFC Bank since inception, his deep experience will be extremely valuable for the Strides Group and Stelis in particular.”
Puri, who led HDFC Bank since its inception over 25 years ago, retired in October 2020, after a highly successful career which has made the bank the largest among private-sector lenders.